Trial intelligence / Profile preview

Oral versus intramuscular ketamine + midazolam + atropine for pediatric dental sedation

IRCT2016030926983N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Sep 2016
Modality
Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ketamine, midazolam and atropine (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2016; status: completed.

02

Drugs

ketaminemidazolamatropine

Beyond the preview

Go deeper on IRCT2016030926983N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2016030926983N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call